FONAR Corporation (FONR)
undefined
undefined%
At close: undefined
15.53
0.52%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.

The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment.

It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies.

The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida.

It markets its scanners to private diagnostic imaging centers and hospitals.

The company was incorporated in 1978 and is based in Melville, New York.

FONAR Corporation
FONAR Corporation logo
Country United States
IPO Date Oct 29, 1981
Industry Medical - Devices
Sector Healthcare
Employees 520
CEO Timothy R. Damadian M.D.

Contact Details

Address:
110 Marcus Drive
Melville, New York
United States
Website https://www.fonar.com

Stock Details

Ticker Symbol FONR
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000355019
CUSIP Number 344437405
ISIN Number US3444374058
Employer ID 11-2464137
SIC Code 3845

Key Executives

Name Position
Timothy R. Damadian M.D. Chairman, President, Chief Executive Officer & Treasurer
Luciano B. Bonanni Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer
Claudette J. V. Chan Secretary & Director
Daniel Culver Director of Communications

Latest SEC Filings

Date Type Title
Dec 13, 2024 8-K Current Report
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 13, 2024 SCHEDULE 13G Filing
Nov 12, 2024 8-K Current Report
Nov 12, 2024 10-Q Quarterly Report
Sep 30, 2024 8-K Current Report
Sep 27, 2024 10-K Annual Report
May 21, 2024 8-K Current Report
May 16, 2024 8-K Current Report
May 15, 2024 10-Q Quarterly Report